EconPapers    
Economics at your fingertips  
 

Dread and Risk Elimination Premium for the Value of a Statistical Life

Sara Olofsson (), Ulf-G. Gerdtham, Lars Hultkrantz and Ulf Persson ()
Additional contact information
Sara Olofsson : The Swedish Institute for Health Economics (IHE), Postal: The Swedish Institute for Health Economics (IHE), Lund, Sweden
Ulf Persson: The Swedish Institute for Health Economics (IHE), Postal: The Swedish Institute for Health Economics (IHE), Lund, Sweden

No 2016:22, Working Papers from Lund University, Department of Economics

Abstract: The Value of a Statistical Life (VSL) is a widely used measure of the value of mortality risk reduction. Since VSL should reflect preferences and attitudes to risk, there are reasons to believe that it varies depending on the type of risk involved. It has been argued that cancer should be considered a “dread disease”, which supports the use of a “cancer premium”. The objective of this study is to elicit the existence and size of a cancer premium (for pancreatic cancer and multiple myeloma) in relation to road traffic accidents, sudden cardiac arrest and Amyotrophic Lateral Sclerosis (ALS). Data was collected from 500 individuals in the Swedish general population 50 -74 years old using a web-based questionnaire. Preferences were elicited using the Contingent Valuation method, and a split-sample design was applied to test for scale sensitivity. VSL differs significantly between contexts, being highest for ALS and lowest for road traffic accident. A premium (26-76 %) for cancer was found in relation to road traffic accidents, but not in relation to ALS and sudden cardiac arrest. The premium was higher for cancer with a shorter time from diagnosis to death. Eliminating risk was associated with a premium of around 17 %. Evidence of scale sensitivity was found when comparing WTP for all risks simultaneously. This study shows that there exist a dread premium and risk elimination premium. These factors should be considered when searching for an appropriate value for economic evaluation and health technology assessment.

Keywords: willingness to pay; value of a statistical life; cancer; contingent valuation; risk elimination (search for similar items in EconPapers)
JEL-codes: D61 D80 I18 J17 (search for similar items in EconPapers)
Pages: 36 pages
Date: 2016-09-23
New Economics Papers: this item is included in nep-hea and nep-rmg
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://lucris.lub.lu.se/ws/portalfiles/portal/194594028/WP16_22 Full text (application/pdf)

Related works:
Journal Article: Dread and Risk Elimination Premium for the Value of a Statistical Life (2019) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hhs:lunewp:2016_022

Access Statistics for this paper

More papers in Working Papers from Lund University, Department of Economics School of Economics and Management, Box 7080, S-22007 Lund, Sweden. Contact information at EDIRC.
Bibliographic data for series maintained by Iker Arregui Alegria ().

 
Page updated 2025-03-31
Handle: RePEc:hhs:lunewp:2016_022